Premium
Effect of Oral Antidiabetic Drug Withdrawal in Type 2 Diabetes
Author(s) -
Nobels F.,
Gaal L.,
Rillaerts E.,
Leeuw I.
Publication year - 1989
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/j.1464-5491.1989.tb02104.x
Subject(s) - postprandial , medicine , discontinuation , type 2 diabetes , drug , diabetes mellitus , insulin , endocrinology , metabolic control analysis , pharmacology
Oral hypoglycaemic agents were withdrawn in 22 Type 2 diabetic patients to establish whether long‐term use of these products is really necessary. Discontinuation of the drugs resulted in significant increases of HbA 1 (8.1 ± 1.1 to 11.3 ± 2.4%) and fasting (9.1 ± 2.1 to 13.6 ± 4.0 mmol l ‐1 ) and postprandial (12.3 ± 3.0 to 18.7 ± 5.7 mmol l ‐1 ) plasma glucose levels after 12 weeks (all p < 0.01). This was associated with a reduction of fasting (12.4 ± 6.2 to 8.0±3.4 mU l ‐1 ) and postprandial (35.7 ± 13.2 to 19.3 ± 13.4 mU l ‐1 ) serum insulin concentrations, and fasting (0.8 ± 0.4 to 0.5 ± 0.2 nmol l ‐1 ) and postprandial (1.8 ± 0.6 to 1.0 ± 0.5 nmol l ‐1 ) serum C‐peptide concentrations (all p < 0.01). Only one patient did not show metabolic deterioration after drug withdrawal. In multivariate analysis no significant correlations could be found between measures of baseline diabetic control and the deterioration after drug withdrawal.